Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CEP85L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM268 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNAP23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEMIS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF101 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DTWD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KBTBD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C17orf51 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
THYN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC31A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP4K5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNOT6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIAS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM219B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RFC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EYA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on